Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
5.56
-0.10 (-1.77%)
Jul 16, 2026, 4:00 PM EDT - Market closed
Verrica Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Verrica Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $15.54. The average 1-year stock price forecast is 179.50% higher than the current stock price, while the lowest is $10 (+79.86%) and the highest is $20 (+259.71%).
Price Target: $15.54 (+179.50%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Verrica Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +115.83% | Jun 22, 2026 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 13, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $20 | Buy | Maintains | $20 | +259.71% | May 13, 2026 |
Financial Forecast
Revenue This Year
25.53M
from 35.58M
Decreased by -28.24%
Revenue Next Year
46.26M
from 25.53M
Increased by 81.20%
EPS This Year
-1.73
from -1.24
EPS Next Year
-1.24
from -1.73
EPS and Forward PE are based on non-GAAP adjusted numbers.